1. A pharmaceutical composition comprising a Form A polymorph of a compound of Formula (X):
wherein the Form A polymorph has an endothermic peak at about 85.3° C. (+5° C.) and at about 214.6° C. (±5° C.) in a differential scanning calorimetry (DSC) thermogram.